Legal scrutiny intensifies over GLP-1 drugs as vision loss cases mount in the US

An accumulating number of lawsuits allege that popular GLP-1 weight-loss and diabetes medications like Ozempic and Wegovy may cause permanent vision loss, raising new questions over drug safety and warning disclosures in the US and Europe. A growing body of…













